Skip to content

English
Français

Careers
Contact Us

About DBV
- Overview
- Leadership
Our Pipeline
- Overview
- Clinical Trials
- VIASKIN^® peanut patch
- VIASKIN^® milk patch
- VIASKIN^® milk patch for EoE
- Expanded Access Program
Our Science
Investors
Newsroom
- Press Releases
- Media Kit

News

News

Select Year
Search News

Found 495 Results

Page 18 of 50« First «...10...16 171819 20...30 40 50...»Last »

February 24, 2021

DBV Technologies to Participate in Upcoming AAAAI 2021 Congress

February 22, 2021

DBV Technologies Announces Appointment of Michele F. Robertson as Chief Legal Officer

February 19, 2021

DBV Technologies to Participate in SVB Leerink Global Partners Healthcare Conference

January 29, 2021

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

January 14, 2021

DBV Technologies Provides Update on Investigational Viaskin™ Peanut for Children Ages 4-11 Years

January 7, 2021

DBV Technologies Announces Change in U.S. Reporting Status and Final Approval of Global Restructuring Process

November 24, 2020

DBV Technologies Announces Leadership Changes

November 10, 2020

DBV Technologies to Highlight Data on Viaskin™ Peanut Treatment Delivery and Patient Experience at ACAAI 2020

November 9, 2020

DBV Technologies to Participate in Upcoming Investor Conferences

November 2, 2020

DBV Technologies Announces Filing and Validation of Marketing Authorization Application for Viaskin™ Peanut by European Medicines Agency

Page 18 of 50« First «...10...16 171819 20...30 40 50...»Last »

Investor Relations Contact

Jonathan Neely

+1 848-388-4584

jonathan.neely@dbv-technologies.com

Media Contact

Brett Whelan

+1 848-350-7622

brett.whelan@dbv-technologies.com

Subscribe to get the latest DBV press releases

About DBV
- Overview
- Leadership
Our Pipeline
Our Science
Investors
News
Careers
Contact Us
English
Français

About DBV
- Overview
- Leadership
Our Pipeline
Our Science
Investors
News
Careers
Contact Us
English
Français

Homepage
About DBV
Our Pipeline
Our Science
News
Investors
Careers
Contact Us

© 2026 DBV Technologies. All rights reserved.
Les traitements de DBV Technologies sont expérimentaux et ne sont pas approuvés par la FDA.

Terms of Use
Privacy Policy
Legal Notice
Your California Privacy Rights

Scroll to Top